Newbridge Financial Services Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $545K | Sell |
|
|||||
|
2025
Q1 | $725K | Sell |
|
|||||
|
2024
Q4 | $953K | Sell |
|
|||||
|
2024
Q3 | $1.19M | Sell |
|
|||||
|
2024
Q2 | $1.17M | Buy |
|
|||||
|
2024
Q1 | $1.16M | Buy |
|
|||||
|
2023
Q4 | $1.08M | Buy |
|
|||||
|
2023
Q3 | $791K | Sell |
|
|||||
|
2023
Q2 | $1M | Sell |
|
|||||
|
2023
Q1 | $930K | Sell |
|
|||||
|
2022
Q4 | $1.09M | Sell |
|
|||||
|
2022
Q3 | $1.08M | Buy |
|
|||||
|
2022
Q2 | $575K | Buy |
|
|||||
|
2022
Q1 | $555K | Buy |
|
|||||
|
2021
Q4 | $336K | Sell |
|
|||||
|
2021
Q3 | $542K | Buy |
|
|||||
|
2021
Q2 | $541K | Buy |
|
|||||
|
2021
Q1 | $461K | Sell |
|
|||||
|
2020
Q4 | $480K | Sell |
|
|||||
|
2020
Q3 | $449K | Buy |
|